Skip to content

Effect of IPACK Block combined with Adductor Canal Block On postoperative analgesia After Total Knee Arthroplasty

Effect of IPACK Block combined with Adductor Canal Block On postoperative analgesia After Total Knee Arthroplasty

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026295
Enrollment
Unknown
Registered
2019-09-29
Start date
2018-08-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

Group 1:IPACK combined with adductor canal block
Group 2:femoral nerve block + sciatic nerve block

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who received unilateral total knee arthroplasty for the first time; 2. The patient is between 50 and 80 years old and can communicate with each other normally to help collect information; 3. the American society of anesthesiologists (ASA) classification I to III level.

Exclusion criteria

Exclusion criteria: 1. Patients who did not sign the informed consent for clinical trials and refused to participate in this study; 2. Previous allergies to any of the drugs used in the study; 3. There are any contraindications associated with nerve block local anesthesia; 4. There are neuromuscular lesions in the surgical limb that affect the limb muscle strength of the patient; 5. Morbidly obese patients (BMI>=40Kg/m2); 6. Patients who cannot communicate normally or cooperate with information collection; 7. Secondary surgery patients and patients with related contraindications of surgical anesthesia; 8. Patients with long-term high opioid use and long-term chronic pain; 9. with history of anaesthetic allergy or blocking lateral nerve damage; 10. with history of serious liver and kidney dysfunction or mental illness; 11. with history of drug dependence.

Design outcomes

Primary

MeasureTime frame
VAS score at rest and dynamic acitivity at Postoperative PACU, 24h, 48h, 72h;the Bromage score;The Quadriceps muscle strength score;The walking distance; the incidence of postoperative remedial analgesia;

Secondary

MeasureTime frame
Intraoperative sufentanil dosage;Intraoperative vital signs changes;

Countries

China

Contacts

Public ContactYingzhi Liu

Affiliated Hospital of Qingdao University

liuyingzhi1967@126.com+86 18661809871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026